Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.
about
Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Dendrimer-doxorubicin conjugat ...... epatocellular carcinoma model.
@en
type
label
Dendrimer-doxorubicin conjugat ...... epatocellular carcinoma model.
@en
prefLabel
Dendrimer-doxorubicin conjugat ...... epatocellular carcinoma model.
@en
P2093
P2860
P1433
P1476
Dendrimer-doxorubicin conjugat ...... hepatocellular carcinoma model
@en
P2093
Gopinath Tiruchinapally
Joan M Greve
Mohamed E H ElSayed
P2860
P304
P356
10.1371/JOURNAL.PONE.0181944
P407
P577
2017-08-22T00:00:00Z